Skip to main content
SpringerLink
Log in

Surgery for Abdominal Well-Differentiated Liposarcoma

  • Sarcoma (SH Okuno, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Retroperitoneal sarcomas are rare tumors of which liposarcoma is the most common histology. Surgical resection remains the mainstay of therapy, particularly for the well-differentiated subtype. They can grow to massive size before causing symptoms or detection. Well-differentiated liposarcoma, while having a negligible metastatic rate, is fraught with a high local recurrence rate, despite a complete surgical resection. Reasons for this are not completely known but may be related to a field defect of the retroperitoneal fat creating a niche for recurrence. These tumors are classically chemo- and radio-resistant. Surgical therapy of recurrences can be challenging, but remains the treatment of choice for well-differentiated liposarcoma. In an attempt to improve on survival and recurrence rates for retroperitoneal liposarcoma, an extended resection approach has been promoted by a few groups. This involves the en bloc resection of contiguous organs that are not macroscopically involved. While this has improved local recurrence rates, benefit for overall survival has not been demonstrated. Interestingly, the improvement in local recurrence rate appeared to be driven by histology and was most improved in the well-differentiated subtype compared to historical data. However, for well-differentiated liposarcomas that are multifocal, this approach may be less useful. The application of this approach still requires further study in terms of balancing increased morbidity of extended resection against the potential for multiple surgeries for recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Explore related subjects

Discover the latest articles, news and stories from top researchers in related subjects.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO classification of tumours of soft tissue and bone (4th), IARC Press, Lyon, 2013.

  2. •• Raut CP, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, et al. External validation of a multi-institutional retroperitoneal sarcoma nomogram. Cancer. 2016;122(9):1417–1424. Multi-institutional, external validation of the retroperitoneal sarcoma nomogram for incorporation into the 8th edition AJCC guidelines. https://doi.org/10.1002/cncr.29931.

  3. Smith CA, Martinez SR, Tseng WH, Tamurian RM, Bold RJ, Borys D, et al. Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res. 2012;175(1):12–7. https://doi.org/10.1016/j.jss.2011.07.024.

  4. Lahat G, Tuvin D, Wei C, Anaya DA, Bekele BN, Lazar AJ, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15(10):2739–48. https://doi.org/10.1245/s10434-008-9970-6.

  5. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238(3):358–70. discussion 70–1

    PubMed  PubMed Central  Google Scholar 

  6. •• Trans-Atlantic RPS Working Group. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2015;22(1):256–263. Consensus guidelines on management of retroperitoneal soft tissue sarcomas from international leaders in sarcoma care. https://doi.org/10.1245/s10434-014-3965-2.

    Article  Google Scholar 

  7. Lahat G, Madewell JE, Anaya DA, Qiao W, Tuvin D, Benjamin RS, et al. Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes. Cancer. 2009;115(5):1081–90. https://doi.org/10.1002/cncr.24045.

  8. Ikoma N, Torres KE, Somaiah N, Hunt KK, Cormier JN, Tseng W, et al. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol. 2015;22(4):1068–72. https://doi.org/10.1245/s10434-014-4210-8.

  9. Strauss DC, Hayes AJ, Thway K, et al. Surgical management of primary retroperitoneal sarcoma. Br J Surg. 2010;101:520–3.

    Google Scholar 

  10. • Bonvalot S, Raut CP, Pollock RE, Rutkowski P, Strauss DC, Hayes AJ, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19(9):2981–2991. Surgical guidelines from European and North American experts in retroperitoneal sarcomas. https://doi.org/10.1245/s10434-012-2342-2.

  11. • Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27(1):24–30. Early, single institution review of extended versus limited resection of retroperitoneal soft tissue sarcomas. https://doi.org/10.1200/JCO.2008.17.8871.

  12. Bonvalot S, Rivoire M, Castaing M, Stoeckle E, le Cesne A, Blay JY, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31–7. https://doi.org/10.1200/JCO.2008.18.0802.

  13. Pisters PW. Resection of some—but not all—clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol. 2009;27(1):6–8. https://doi.org/10.1200/JCO.2008.18.7138.

    Article  PubMed  Google Scholar 

  14. • Tseng WW, Madewell JE, Wei W, Somaiah N, Lazar AJ, Ghadimi MP, et al. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014;21(7):2136–2143. Locoregional disease and recurrence patterns in WDLPS and DDLPS. https://doi.org/10.1245/s10434-014-3643-4.

  15. MacNeill AJ, Gronchi A, Miceli R, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the transatlantic RPS Working Group. Ann Surg. 2017, DOI: https://doi.org/10.1016/j.fas.2016.09.004.

  16. Jones RL, Fisher C, Al-Muderis O, Judson IR. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer. 2005;41(18):2853–60. https://doi.org/10.1016/j.ejca.2005.07.023.

    Article  CAS  PubMed  Google Scholar 

  17. Italiano A, Toulmonde M, Cioffi A, Penel N, Isambert N, Bompas E, et al. Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival. Ann Oncol. 2012;23(6):1601–7. https://doi.org/10.1093/annonc/mdr485.

  18. Sanfilippo R, Bertulli R, Marrari A, Fumagalli E, Pilotti S, Morosi C, et al. High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma. Clin Sarcoma Res. 2014;4(1):16. https://doi.org/10.1186/2045-3329-4-16.

  19. Datta J, Ecker BL, Neuwirth MG, Geha RC, Fraker DL, Roses RE, et al. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: evidence from a nationwide clinical oncology database and review of the literature. Surg Oncol. 2017;26(2):117–24. https://doi.org/10.1016/j.suronc.2017.01.008.

  20. Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol. 2010;101(5):345–50. https://doi.org/10.1002/jso.21474.

    PubMed  Google Scholar 

  21. Molina G, Hull MA, Chen YL, DeLaney TF, de Amorim Bernstein K, Choy E, et al. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma. J Surg Oncol. 2016;114(7):814–20. https://doi.org/10.1002/jso.24427.

  22. Hull MA, Molina G, Niemierko A, Haynes AB, Jacobson A, Bernstein KDA, et al. Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with radical surgical resection for retroperitoneal sarcoma. J Surg Oncol. 2017;115(6):746–51. https://doi.org/10.1002/jso.24557.

  23. Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, et al. Combined modality management of retroperitoneal sarcomas: a single-institution series of 121 patients. Int J Radiat Oncol Biol Phys. 2015;93(1):158–65. https://doi.org/10.1016/j.ijrobp.2015.04.047.

  24. Surgery with or without Radiation Therapy in Treating Patients with Previously Untreated Nonmetastatic Retroperitoneal Soft Tissue Sarcoma (STRASS). http://clinicaltrials.giv/ct2/show/NCT01344018. Accessed Oct 2017.

  25. Callegaro D, Miceli R, Mariani L, Raut CP, Gronchi A. Soft tissue sarcoma nomograms and their incorporation into practice. Cancer. 2017;123(15):2802–20. https://doi.org/10.1002/cncr.30721.

    Article  PubMed  Google Scholar 

  26. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20(3):791–6. https://doi.org/10.1200/JCO.2002.20.3.791.

    Article  PubMed  Google Scholar 

  27. Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244(3):381–91. https://doi.org/10.1097/01.sla.0000234795.98607.00.

    PubMed  PubMed Central  Google Scholar 

  28. • Gronchi A, Miceli R, Shurell E, Eilber FC, Eilber FR, Anaya DA, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31(13):1649–1655. Multi-center creation of a nomogram for post-operative overall survival and disease-free survival in patients with retroperitoneal soft tissue sarcomas. https://doi.org/10.1200/JCO.2012.44.3747.

  29. Bonvalot S, Miceli R, Berselli M, Causeret S, Colombo C, Mariani L, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17(6):1507–14. https://doi.org/10.1245/s10434-010-1057-5.

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, The Ohio State University, Columbus, OH, USA

    Sara A. Mansfield MD, MS

  2. Division of Surgical Oncology, Department of Surgery, The Ohio State University, N924 Doan Hall, 410 West 10th Avenue, Columbus, OH, 43210, USA

    Raphael E. Pollock MD, PhD & Valerie P. Grignol MD

Authors
  1. Sara A. Mansfield MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raphael E. Pollock MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valerie P. Grignol MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valerie P. Grignol MD.

Ethics declarations

Conflict of Interest

The authors declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Sarcoma

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mansfield, S.A., Pollock, R.E. & Grignol, V.P. Surgery for Abdominal Well-Differentiated Liposarcoma. Curr. Treat. Options in Oncol. 19, 1 (2018). https://doi.org/10.1007/s11864-018-0520-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-018-0520-6

Keywords

Search

Navigation